May the robotic approach expand the indications for redo surgery in recurrent pNETs in Multiple Neuroendocrine Neoplasia type 1?. Issue 9 (20th September 2022)

• Record Type: Journal Article
• Authors: Baz, Carolina; Dreifuss, Nicolas H; Cubisino, Antonio; Schlottmann, Francisco; Mangano, Alberto; Aguiluz, Gabriela; Vanetta, Carolina; Masrur, Mario A; Giulianotti, Pier Cristoforo
• Is Part Of: Journal of surgical case reports. Volume 2022:Issue 9(2022)
• Publication Date: 2022-09-20
• Subjects: Surgery -- Periodicals; Surgery -- Case studies -- Periodicals; 617.005
• DOI: 10.1093/jscr/rjac433
• Languages: English
• ISSNs: 2042-8812

Abstract

Abstract: Pancreatic neuroendocrine tumors (pNETs) represent the leading cause of disease-specific mortality in patients with Multiple Neuroendocrine Neoplasia type 1 (MEN1). Although surgery is the recommended treatment for non-functional pNETs >2 cm, the management of recurrent lesions between 1 and 2 cm is controversial. Robotic surgery was used on a 29-year-old female with MEN1 and previous distal splenopancreatectomy that presented with a 1 cm recurrent pNET. The advantages offered by this approach facilitating a precise resection of the tumor and minimizing the postoperative morbidity may favor the decision towards redo surgery for local recurrences <2 cm, expanding current indications.